Lectin-like oxidized low-density lipoprotein receptor (LOX-1) in sickle cell disease vasculopathy
- 1 September 2016
- journal article
- research article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 60, 44-48
Abstract
No abstract availableKeywords
Funding Information
- University of California Davis Health System Vision (FL16MCX)
- Bayer Pharma AG Grants4Targets (2014-08-1145)
This publication has 27 references indexed in Scilit:
- LOX-1, OxLDL, and AtherosclerosisMediators of Inflammation, 2013
- Comparison of real‐time microvascular abnormalities in pediatric and adult sickle cell anemia patientsAmerican Journal of Hematology, 2010
- LOX Index, a Novel Predictive Biochemical Marker for Coronary Heart Disease and StrokeClinical Chemistry, 2010
- Sickle Red Cell–Endothelium InteractionsMicrocirculation, 2009
- Primary Hemorrhagic Stroke in Children With Sickle Cell Disease Is Associated With Recent Transfusion and Use of CorticosteroidsPediatrics, 2006
- Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*Clinical and Laboratory Haematology, 2002
- Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*Clinical and Laboratory Haematology, 2002
- Diabetes Enhances Lectin-like Oxidized LDL Receptor-1 (LOX-1) Expression in the Vascular Endothelium: Possible Role of LOX-1 Ligand and AGEBiochemical and Biophysical Research Communications, 2001
- Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium.Journal of Clinical Investigation, 1997
- An endothelial receptor for oxidized low-density lipoproteinNature, 1997